Fuel Cells Science and Technology in September 2008

Elsevier will hold the conference in Copenhagen, October 8-9

Oxford, UK, 12 December 2007 – Elsevier, the world-leading publisher of scientific, technical and medical information products and services is pleased to announce that it will hold the Fuel Cells Science & Technology 2008 event on 8-9 October 2008. Following the success of the previous three events, the fourth event in the series will be held at the Confederation of Danish Industries, Copenhagen, Denmark.

International delegates to this two-day conference will have the opportunity to find out about the latest advances in fuel cell systems and meet with engineers and researchers from across the globe.
With the recent appearance of the new Honda FCX Clarity on the popular UK BBC show TopGear and BMW manufacturing one hundred hydrogen powered 7-Series cars, it is evident that fuel cells are emerging onto the consumer market. The popularity of alternative, greener cars is certainly apparent in California too, where governor Arnold Schwarzenegger is planning to build a string of hydrogen filling stations along the Pacific coast of the US, dubbed ‘hydrogen highway’. To discuss the most recent issues in fuel cell systems and find out about the latest advances in cell and stack technology, join international experts at the Fuel Cells Science & Technology 2008 event, taking place in Copenhagen.
To be part of this conference, or to submit your findings and present at the 2008 conference, visit www.fuelcelladvances.com. The closing date for abstract submissions is 8 February 2008. 

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact:
Kelly Rogers
Elsevier
+44 1865 843181
k.rogers@elsevier.com